{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T10:56:15Z","timestamp":1790592975119,"version":"4.1.0"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":265,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research Reports"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.lrr.2026.100613","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T07:18:07Z","timestamp":1790320687000},"page":"100613","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["TIF1\/TRIM24::FGFR1-rearranged myeloid\/lymphoid neoplasm with eosinophilia and tyrosine kinase gene fusion presenting as mixed-phenotype acute leukemia: a case report"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-5727-3767","authenticated-orcid":false,"given":"Rong","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shasha","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengcheng","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lrr.2026.100613_bib0001","article-title":"The 8p11 myeloproliferative syndrome: genotypic and phenotypic classification and targeted therapy","volume":"12","author":"Li","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.lrr.2026.100613_bib0002","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.lrr.2026.100613_bib0003","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.lrr.2026.100613_bib0004","doi-asserted-by":"crossref","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the world health organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.lrr.2026.100613_bib0005","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.humpath.2009.11.003","article-title":"8p11 myeloproliferative syndrome: a review","volume":"41","author":"Jackson","year":"2010","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.lrr.2026.100613_bib0006","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/leu.2015.136","article-title":"Clinical activity of ponatinib in a patient with FGFR1-rearranged mixed-phenotype acute leukemia","volume":"30","author":"Khodadoust","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.lrr.2026.100613_bib0007","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000341289","article-title":"A case of 8p11 myeloproliferative syndrome with BCR-FGFR1 gene fusion presenting with trilineage acute leukemia\/lymphoma, successfully treated by cord blood transplantation","volume":"129","author":"Morishige","year":"2013","journal-title":"Acta Haematol."},{"key":"10.1016\/j.lrr.2026.100613_bib0008","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3343\/alm.2022.42.4.485","article-title":"The first case of B-lymphoblastic leukemia associated with t(7;8)(q34;p11.2) and FGFR1 rearrangement","volume":"42","author":"Cho","year":"2022","journal-title":"Ann. Lab. Med."},{"key":"10.1016\/j.lrr.2026.100613_bib0009","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/med.21288","article-title":"FGF receptors: cancer biology and therapeutics","volume":"34","author":"Katoh","year":"2014","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.lrr.2026.100613_bib0010","first-page":"1","article-title":"RTK\/Ras\/MAPK signaling","author":"Sundaram","year":"2006","journal-title":"WormB. Online Rev. C Elegans Biol."},{"key":"10.1016\/j.lrr.2026.100613_bib0011","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cytogfr.2005.01.001","article-title":"Cellular signaling by fibroblast growth factor receptors","volume":"16","author":"Eswarakumar","year":"2005","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.lrr.2026.100613_bib0012","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1182\/blood-2016-10-687830","article-title":"Role of RUNX1 in hematological malignancies","volume":"129","author":"Sood","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.lrr.2026.100613_bib0013","article-title":"Significance of myelodysplasia-related mutations and the genetic landscape of acute leukemias of ambiguous lineage","author":"Kirtek","year":"2025","journal-title":"Int. J. Lab. Hematol."},{"key":"10.1016\/j.lrr.2026.100613_bib0014","article-title":"The 8p11 myeloproliferative syndrome: genotypic and phenotypic classification and targeted therapy","volume":"12","author":"Li","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.lrr.2026.100613_bib0015","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1080\/10245332.2018.1446279","article-title":"Clinical outcomes of myeloid\/lymphoid neoplasms with fibroblast growth factor receptor-1 (FGFR1) rearrangement","volume":"23","author":"Umino","year":"2018","journal-title":"Hematol."},{"key":"10.1016\/j.lrr.2026.100613_bib0016","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/16078454.2020.1854493","article-title":"Myeloid\/lymphoid neoplasm with CEP110-FGFR1 fusion: an analysis of 16 cases show common features and poor prognosis","volume":"26","author":"Chen","year":"2021","journal-title":"Hematol."},{"key":"10.1016\/j.lrr.2026.100613_bib0017","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/s41409-018-0287-1","article-title":"Allogeneic hematopoietic stem cell transplantation for 8p11 myeloproliferative syndrome with BCR-FGFR1 gene rearrangement: a case report and literature review","volume":"54","author":"Konishi","year":"2019","journal-title":"Bone Marrow Transpl."},{"key":"10.1016\/j.lrr.2026.100613_bib0018","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S1470-2045(20)30109-1","article-title":"Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study","volume":"21","author":"Abou-Alfa","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.lrr.2026.100613_bib0019","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S2468-1253(21)00196-5","article-title":"Infigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multicentre, open-label, single-arm, phase 2 study","volume":"6","author":"Javle","year":"2021","journal-title":"Lancet Gastroenterol. Hepatol."}],"container-title":["Leukemia Research Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048926000531?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048926000531?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T10:02:55Z","timestamp":1790589775000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213048926000531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":19,"alternative-id":["S2213048926000531"],"URL":"https:\/\/doi.org\/10.1016\/j.lrr.2026.100613","relation":{},"ISSN":["2213-0489"],"issn-type":[{"value":"2213-0489","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TIF1\/TRIM24::FGFR1-rearranged myeloid\/lymphoid neoplasm with eosinophilia and tyrosine kinase gene fusion presenting as mixed-phenotype acute leukemia: a case report","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lrr.2026.100613","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100613"}}